Varian Medical Systems, Inc. (NYSE:VAR) – Equities research analysts at Barrington Research lowered their FY2017 earnings estimates for shares of Varian Medical Systems in a report released on Thursday. Barrington Research analyst M. Petusky now forecasts that the medical equipment provider will post earnings of $4.02 per share for the year, down from their prior estimate of $4.04. Barrington Research currently has a “Market Perform” rating on the stock. Barrington Research also issued estimates for Varian Medical Systems’ Q1 2018 earnings at $0.93 EPS and Q4 2018 earnings at $1.26 EPS.

A number of other analysts have also recently commented on the company. BidaskClub cut Varian Medical Systems from a “strong-buy” rating to a “buy” rating in a research report on Monday. Robert W. Baird restated a “neutral” rating and issued a $99.00 price objective (up from $89.00) on shares of Varian Medical Systems in a research report on Friday, July 14th. Zacks Investment Research cut Varian Medical Systems from a “buy” rating to a “hold” rating in a research report on Thursday, July 13th. Aegis restated a “hold” rating and issued a $91.00 price objective on shares of Varian Medical Systems in a research report on Wednesday, May 17th. Finally, Goldman Sachs Group, Inc. (The) started coverage on Varian Medical Systems in a research report on Tuesday, May 16th. They set a “neutral” rating and a $92.00 price target for the company. Three equities research analysts have rated the stock with a sell rating, six have issued a hold rating and five have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average price target of $94.21.

TRADEMARK VIOLATION NOTICE: This story was published by American Banking News and is the sole property of of American Banking News. If you are viewing this story on another domain, it was illegally copied and reposted in violation of United States and international copyright and trademark laws. The original version of this story can be accessed at https://www.americanbankingnews.com/2017/07/28/varian-medical-systems-inc-var-expected-to-post-fy2017-earnings-of-4-02-per-share.html.

Varian Medical Systems (NYSE:VAR) traded down 2.33% during midday trading on Friday, hitting $97.86. 434,918 shares of the stock traded hands. The company has a 50-day moving average of $103.64 and a 200-day moving average of $92.06. The stock has a market cap of $9.00 billion, a PE ratio of 31.58 and a beta of 0.62. Varian Medical Systems has a 12 month low of $75.20 and a 12 month high of $107.08.

Varian Medical Systems (NYSE:VAR) last posted its earnings results on Wednesday, July 26th. The medical equipment provider reported $1.04 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.95 by $0.09. Varian Medical Systems had a net margin of 9.39% and a return on equity of 24.82%. The business had revenue of $662.40 million for the quarter, compared to analysts’ expectations of $663.86 million. During the same quarter in the prior year, the business earned $1.00 EPS. The business’s revenue for the quarter was up 3.0% compared to the same quarter last year.

In other Varian Medical Systems news, SVP John W. Kuo sold 862 shares of the company’s stock in a transaction on Friday, May 12th. The stock was sold at an average price of $96.39, for a total value of $83,088.18. Following the completion of the sale, the senior vice president now directly owns 28,223 shares in the company, valued at approximately $2,720,414.97. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Susan L. Bostrom sold 3,589 shares of the company’s stock in a transaction on Tuesday, May 2nd. The shares were sold at an average price of $91.08, for a total value of $326,886.12. Following the completion of the sale, the director now owns 3,809 shares of the company’s stock, valued at $346,923.72. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 147,676 shares of company stock valued at $14,979,214. 0.91% of the stock is owned by company insiders.

A number of hedge funds have recently modified their holdings of the stock. First Mercantile Trust Co. boosted its stake in shares of Varian Medical Systems by 2.3% in the first quarter. First Mercantile Trust Co. now owns 1,093 shares of the medical equipment provider’s stock valued at $100,000 after buying an additional 25 shares during the last quarter. Parallel Advisors LLC boosted its stake in shares of Varian Medical Systems by 16.7% in the first quarter. Parallel Advisors LLC now owns 1,232 shares of the medical equipment provider’s stock valued at $113,000 after buying an additional 176 shares during the last quarter. Heritage Trust Co bought a new stake in shares of Varian Medical Systems during the first quarter valued at about $118,000. Penserra Capital Management LLC boosted its stake in shares of Varian Medical Systems by 9.5% in the first quarter. Penserra Capital Management LLC now owns 1,610 shares of the medical equipment provider’s stock valued at $146,000 after buying an additional 140 shares during the last quarter. Finally, Pacer Advisors Inc. boosted its stake in shares of Varian Medical Systems by 3.1% in the first quarter. Pacer Advisors Inc. now owns 1,815 shares of the medical equipment provider’s stock valued at $165,000 after buying an additional 55 shares during the last quarter. Institutional investors own 99.52% of the company’s stock.

Varian Medical Systems Company Profile

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Earnings History and Estimates for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.